| Matthew Alexander Reasinger, OTR/L | |
|
101 Delaware Ave, Delmar, DE 19940-1110 | |
| (302) 846-3077 | |
| Not Available |
| Full Name | Matthew Alexander Reasinger |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 101 Delaware Ave, Delmar, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134641970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Fox Rehabilitation Physical Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1174560650 PECOS PAC ID: 1355395179 Enrollment ID: O20061023000060 |
News Archive
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
The number of bariatric surgeries in the U.S. skyrocketed from 13,386 in 1998 to 220,000 in 2008, but a new study released today by HealthGrades, the leading independent healthcare ratings organization, finds that the nation's hospitals have wide variances in both complication rates and lengths of stay, which largely correlate with the number of times the hospital performs bariatric procedures.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
A team of researchers from Cardiff University and Monash Biomedicine Discovery Institute has succeeded in creating a three-dimensional mammary gland model that will pave the way for a better understanding of the mechanisms of breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Alexander Reasinger, OTR/L 120 N State St, Du Bois, PA 15801-1774 Ph: () - | Matthew Alexander Reasinger, OTR/L 101 Delaware Ave, Delmar, DE 19940-1110 Ph: (302) 846-3077 |
News Archive
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
The number of bariatric surgeries in the U.S. skyrocketed from 13,386 in 1998 to 220,000 in 2008, but a new study released today by HealthGrades, the leading independent healthcare ratings organization, finds that the nation's hospitals have wide variances in both complication rates and lengths of stay, which largely correlate with the number of times the hospital performs bariatric procedures.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
A team of researchers from Cardiff University and Monash Biomedicine Discovery Institute has succeeded in creating a three-dimensional mammary gland model that will pave the way for a better understanding of the mechanisms of breast cancer.
› Verified 2 days ago
Patricia Bradley, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Delaware Ave, Delmar, DE 19940 Phone: 302-846-3463 Fax: 302-846-3462 | |
Katelin Tull, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Delaware Ave, Delmar, DE 19940 Phone: 302-846-3077 |